Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-11

Clinical Trial Update: Study Evaluating the Efficacy of Different Mixes of HMO-2FL + Humiome® Post LB on IBS Gastrointestinal Symptoms [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating the efficacy of mixes of HMO-2FL and Humiome for irritable bowel syndrome. The trial is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HMO-2FL
  • Humiome

Snippet

Sponsor: dsm-firmenich Switzerland AG | Conditions: IBS (Irritable Bowel Syndrome) | NA | Status: RECRUITING